Curosurf® is indicated for treatment of premature infants with respiratory distress syndrome resulting from surfactant deficiency or at high risk of developing such a syndrome1
Curosurf®
200 mg/kg1 provides
unique clinical benefits
Curosurf® administration
Curosurf® is administered as a bolus via an endotracheal tube deep into the trachea using 4 different methods1:
Using the LISA method
After a brief interruption in mechanical ventilation
Without disconnecting the infant from the ventilator
You are briefly leaving Omniamed to get redirected to Swiss-Rx for login/registration. Once registered, you are going to be brought back here on the last visited page.
OM Pharma could not be held responsible for the website content, services or experience you might find at Swiss-Rx-login.ch. Be always mindful of phishing attacks or any cybersecurity threats involving your personal information.
